Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Multi-Center, Long-Term, Repeat-Treatment, Open-Label, Single-Arm Trial to Demonstrate the Safety of Repeat Treatment With PurTox® for the Treatment of Glabellar Rhytides ("Frown Lines")

NCT00752258 is registered in ClinicalTrials.gov with Mentor Worldwide, LLC as lead sponsor.

NCT NCT00752258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00752258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Multi-Center, Long-Term, Repeat-Treatment, Open-Label, Single-Arm Trial to Demonstrate the Safety of Repeat Treatment With PurTox® for the Treatment of Glabellar Rhytides ("Frown Lines")
Lead sponsor
Mentor Worldwide, LLC
Phase
Phase 3
Overall status
Completed
Start date
February 29, 2008
Completion date
May 31, 2011
Enrollment
576 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glabellar rhytides